Reduced risk of Efavirenz Discontinuation in Naïve Patients Starting First-Line Antiretroviral Therapy with Single Tablet versus dual Tablet Regimen

Massimiliano Fabbiani; M Zaccarelli; A Latini; G Sterrantino; G D'Ettorre; P Grima; Annalisa Mondi; Barbara Rossetti; B Borchi; M Giuliani; A Antinori; Andrea De Luca; Simona Di Giambenedetto

doi:10.1111/hiv.12313

Reduced risk of Efavirenz Discontinuation in Naïve Patients Starting First-Line Antiretroviral Therapy with Single Tablet versus dual Tablet Regimen

Massimiliano Fabbiani^*
, M Zaccarelli
, A Latini
, G Sterrantino
, G D'Ettorre
, P Grima
, Annalisa Mondi
, Barbara Rossetti
, B Borchi
, M Giuliani
, A Antinori
, Andrea De Luca
, Simona Di Giambenedetto

^*Autore corrispondente per questo lavoro

Risultato della ricerca: Contributo in rivista › Articolo

4 Citazioni (Scopus)

Abstract

Despite not being approved in Europe as first-line therapy, the efavirenz (EFV)-containing single tablet regimen (STR) is frequently used in clinical practice in naïve patients but few data are available on this strategy. In our study, we aimed to assess the risk of EFV discontinuation in patients starting antiretroviral therapy with STR vs. nonSTR.

Lingua originale	Inglese
pagine (da-a)	N/A-N/A
Rivista	HIV Medicine
Numero di pubblicazione	Settembre
DOI	https://doi.org/10.1111/hiv.12313
Stato di pubblicazione	Pubblicato - 2015

All Science Journal Classification (ASJC) codes

Politiche della Salute
Malattie Infettive
Farmacologia (medica)

Keywords

STR
adherence
cART
combination antiretroviral therapy
toxicity

Accesso al documento

10.1111/hiv.12313

Altri file e collegamenti

Cita questo

Fabbiani, M., Zaccarelli, M., Latini, A., Sterrantino, G., D'Ettorre, G., Grima, P., Mondi, A., Rossetti, B., Borchi, B., Giuliani, M., Antinori, A., De Luca, A., & Di Giambenedetto, S. (2015). Reduced risk of Efavirenz Discontinuation in Naïve Patients Starting First-Line Antiretroviral Therapy with Single Tablet versus dual Tablet Regimen. HIV Medicine, (Settembre), N/A-N/A. https://doi.org/10.1111/hiv.12313

@article{84b18ed61f144a78b048ab89ae30ea55,

title = "Reduced risk of Efavirenz Discontinuation in Na{\"i}ve Patients Starting First-Line Antiretroviral Therapy with Single Tablet versus dual Tablet Regimen",

abstract = "Despite not being approved in Europe as first-line therapy, the efavirenz (EFV)-containing single tablet regimen (STR) is frequently used in clinical practice in na{\"i}ve patients but few data are available on this strategy. In our study, we aimed to assess the risk of EFV discontinuation in patients starting antiretroviral therapy with STR vs. nonSTR.",

keywords = "STR, adherence, cART, combination antiretroviral therapy, toxicity, STR, adherence, cART, combination antiretroviral therapy, toxicity",

author = "Massimiliano Fabbiani and M Zaccarelli and A Latini and G Sterrantino and G D'Ettorre and P Grima and Annalisa Mondi and Barbara Rossetti and B Borchi and M Giuliani and A Antinori and \{De Luca\}, Andrea and \{Di Giambenedetto\}, Simona",

year = "2015",

doi = "10.1111/hiv.12313",

language = "English",

pages = "N/A--N/A",

journal = "HIV Medicine",

issn = "1464-2662",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "Settembre",

}

Fabbiani, M, Zaccarelli, M, Latini, A, Sterrantino, G, D'Ettorre, G, Grima, P, Mondi, A, Rossetti, B, Borchi, B, Giuliani, M, Antinori, A, De Luca, A & Di Giambenedetto, S 2015, 'Reduced risk of Efavirenz Discontinuation in Naïve Patients Starting First-Line Antiretroviral Therapy with Single Tablet versus dual Tablet Regimen', HIV Medicine, n. Settembre, pagg. N/A-N/A. https://doi.org/10.1111/hiv.12313

TY - JOUR

T1 - Reduced risk of Efavirenz Discontinuation in Naïve Patients Starting First-Line Antiretroviral Therapy with Single Tablet versus dual Tablet Regimen

AU - Fabbiani, Massimiliano

AU - Zaccarelli, M

AU - Latini, A

AU - Sterrantino, G

AU - D'Ettorre, G

AU - Grima, P

AU - Mondi, Annalisa

AU - Rossetti, Barbara

AU - Borchi, B

AU - Giuliani, M

AU - Antinori, A

AU - De Luca, Andrea

AU - Di Giambenedetto, Simona

PY - 2015

Y1 - 2015

N2 - Despite not being approved in Europe as first-line therapy, the efavirenz (EFV)-containing single tablet regimen (STR) is frequently used in clinical practice in naïve patients but few data are available on this strategy. In our study, we aimed to assess the risk of EFV discontinuation in patients starting antiretroviral therapy with STR vs. nonSTR.

AB - Despite not being approved in Europe as first-line therapy, the efavirenz (EFV)-containing single tablet regimen (STR) is frequently used in clinical practice in naïve patients but few data are available on this strategy. In our study, we aimed to assess the risk of EFV discontinuation in patients starting antiretroviral therapy with STR vs. nonSTR.

KW - STR

KW - adherence

KW - cART

KW - combination antiretroviral therapy

KW - toxicity

KW - STR

KW - adherence

KW - cART

KW - combination antiretroviral therapy

KW - toxicity

UR - https://publicatt.unicatt.it/handle/10807/68426

UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=84945295430&origin=inward

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84945295430&origin=inward

U2 - 10.1111/hiv.12313

DO - 10.1111/hiv.12313

M3 - Article

SN - 1464-2662

SP - N/A-N/A

JO - HIV Medicine

JF - HIV Medicine

IS - Settembre

ER -

Reduced risk of Efavirenz Discontinuation in Naïve Patients Starting First-Line Antiretroviral Therapy with Single Tablet versus dual Tablet Regimen

Abstract

All Science Journal Classification (ASJC) codes

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo